H
Hygea Medical Technology
Hygea Medical Technology is a oncology-focused biopharma company
About Hygea Medical Technology
Hygea Medical is a National High-tech Enterprise specializing in the field of Interventional Oncology, focusing on percutaneous and transvascular interventions. The company's flagship product, the Co Ablation System, integrates cryoablation and hyperthermia ablation into a single system, making it a pioneering solution in the industry. This system has received the CE Marking Certificate and is marketed across European countries. The Co Ablation System AI Epic series has also won the prestigious iF DESIGN AWARD 2020. Hygea Medical operates a Beijing Key Laboratory of Cryogenic Biomedical Engineering and a Post-Doctoral Research Center, and holds over 150 patents globally. The company serves hospitals and medical institutions, providing advanced solutions for minimally invasive tumor treatments. Its business model revolves around the research, development, production, and sales of cutting-edge medical technologies, generating revenue through product sales and strategic partnerships.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Feb 2023 | $29M | $385M | Qiandao Fund · Rongquan Capital · Gaorong Capital · Huajin Capital | ↗ |
| SERIES COther financing | Apr 2021 | $77M | $308M | China Growth Capital · Chinese Reform Holdings Corporation · Sinopharm Capital · BioTrack Capital | — |
Growth signals
Latest recorded traffic for Hygea Medical Technology is 1.7K monthly website visits, up 295.3% over the last three months. Hygea Medical Technology's team grew 4.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hygea Medical Technology in the Shunyi District ecosystem
The Hygea Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- JIJinrong Medical Investment
- LILihe Technology Innovation
Series B and later10 investors entered at this stage
China Growth Capital- CCChinese Reform Holdings Corporation
- SCSinopharm Capital
BioTrack Capital- QFQiandao Fund
- RCRongquan Capital
Gaorong Capital
Huajin Capital- YFYueyin Medical Fund
- MFMeihong Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hygea Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hygea Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









